跳至主要内容
临床试验/NCT05370079
NCT05370079招募中不适用

Control Cohort CTRL COH

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2023年8月8日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
350
试验地点
1
主要终点
Samples (blood dry and EDTA tube and optional cerebro-spinal-fluid)

研究概览

简要总结

Autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS) are rare disease that could be difficult to diagnose. So it necessary to obtain numerous sample from different disease to develop more specific diagnosis kit It could be possible through the characterisation of new genetic biomarkers.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient with consent
  • patient with following disease: Parkinson's disease, Amyotrophic lateral sclerosis, Glioblastoma, cancer without neurological disease (pulmonary cancer, breast cancer, ovarian cancer, melanoma, thymoma), rheumatoid arthritis.

排除标准

  • refusal consent
  • patient with neurological disorder compatible with paraneoplastic neurological syndrome or auto-immune encephalitis
  • patient under guardianship

研究组 & 干预措施

Control cohort

Other

Patient with following disease: Parkinson's disease, Amyotrophic lateral sclerosis, Glioblastoma, cancer without neurological disease (pulmonary cancer, breast cancer, ovarian cancer, melanoma, thymoma), rheumatoid arthritis.

干预措施: Collection of biological sample (blood and/or CSF) (Biological)

结局指标

主要结局

Samples (blood dry and EDTA tube and optional cerebro-spinal-fluid)

时间窗: 15 minutes

Numbers of samples collected and patients included in the cohort

次要结局

  • Description of genetic analysis(Data collecting: 3 years Data analysis: 2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验